Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xylogenics

Xylogenics
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$525K LATEST DEAL AMOUNT
Description

Provider of a yeast genomics platform. The company is engaged in the the engineering of modified yeast microorganisms to synthesize commercial chemicals.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • 351 West 10th Street
  • Indianapolis, IN 46202
  • United States

+1 (317) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xylogenics’s full profile, request a free trial.

Xylogenics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Convertible Debt 20-Dec-2010 $525K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Xylogenics Executive Team (5)

Name Title Board
Seat
Contact
Info
Joshua Heyen Ph.D Chief Executive Officer, President & Co-Founder
Matt Kelker Ph.D Chief Scientific Officer
Cary Woods Co-Founder

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »